Standard & Poors
No.12G Reg.823486
For Immediate Release NEWS RELEASE
CEAPRO INC. - NEW DIRECTORS
Edmonton - August 14, 1998-- Ceapro Inc. ("Ceapro") (ASE: CZO) announced today the appointment of three new Directors, subject to regulatory approval. Joining the Ceapro Inc. Board of Directors are Mr. John Zupancic, Mr. Ken Ruptash, and Mr. Peter Ulrich.
Mr. Zupancic is a significant Ceapro shareholder and has been a shareholder since the early stages of Ceapro. Mr. Zupancic is an entrepreneur and management consultant involved in technology commercialization. Prior to this, he was President and CEO of the Alberta Microelectronic Centre.
Mr. Ken Ruptash, a shareholder in Ceapro Inc., is Vice President and General Manager of Midwest Television Ltd. and Sask-Alta Broadcasters Limited, operators of CITL-TV, CKSA-TV, and CKSA Radio. Mr. Ruptash is also a Director of Craig Broadcasting, Alberta.
Mr. Ulrich is President and CEO of NeuroVir Inc., a biopharmaceutical company based in Vancouver, British Columbia, which is developing products to treat cancer, nervous system diseases, and other disorders. Prior to this, Mr. Ulrich was Executive Vice President of La Jolla Pharmaceutical Co. in San Diego, California.
Messrs. Zupancic, Ruptash, and Ulrich bring to Ceapro extensive business, technology, and pharmaceutical experience. "We are delighted to have these three people join the Ceapro Board," stated Bob Binnendyk, President and CEO. Ceapro has developed a novel Diabetes Screening Product for the purpose of identifying people who have Impaired Glucose Tolerance or Type II Diabetes. Ceapro is in the advanced stages of discussions with a major international pharmaceutical company relative to this product.
-30-
For more information contact
Robert A. Binnendyk, President & CEO
Ceapro Inc.
Telephone (403) 421-4555
- The ASE has neither approved nor disapproved of the information contained herein - |
